Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI

NCT00488761 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Diseases, Infectious

Interventions

DRUG: Tigecycline

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer